Low back pain
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial. Approximately 60 individuals will be included in the study, divided into two groups: placebo (N = 30) and active TENS (N = 30). T
E02.331.800
Sponsors
Universidade Federal de Santa Catarina
Universidade Federal de Santa Catarina
Eligibility
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 45 years; presence of low back pain measured by the numerical visual scale of greater than or equal to 3 at the time of evaluation
Exclusion criteria
Exclusion criteria: Individuals who underwent pharmacological or non-pharmacological treatments for low back pain less than 48 hours before the evaluation; pregnant women; patients undergoing spinal surgery; individuals with diagnoses of pathologies in the spine such as herniated disc; spondylolisthesis; spinal canal stenosis; equine cause syndrome; fractures; cancer; individuals who have any contraindications to the use of electrotherapy, such as the presence of skin lesions; abnormal sensitivity; infectious; blood diseases; cardiac pacemakers; inability to answer questionnaires; electrophobia; fibromyalgia; psychiatric problems; refusal to sign the Free and Informed Consent Form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to found a clinically relevant three-point reduction in Visual Numerical Pain Scale (VAS) value immediately after the intervention and at the follow-up (one week after the intervention) for the active TENS group. For the placebo group, it is expected that there will be no reduction in the VAS scale at any time. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that TENS active mode will reduce the Oswestry Disability Index values by 10% after one week of intervention, which indicates less disability related to nonspecific low back pain, when compared to TENS placebo mode. In the placebo group, no change is expected.;It is expected that the TENS active mode will increase immediately after the intervention by 10% the isometric time values, since a reduction in pain will possibly occur. In the placebo group, no change is expected.; It is expected that in the active mode TENS group there will be a reduction of 20 points on the Tampa Scale for Kinesiophobia after one week after the intervention, which represents less kinesiophobia. In the placebo group, no change is expected. | — |
Countries
Brazil
Contacts
Public ContactKelly Marinho e Lima
Universidade Federal de Santa Catarina
Outcome results
None listed